Imagin Medical to Report Second Fiscal Quarter 2019 Financial Results on June 11, 2019 – Conference Call to Follow
03 Giugno 2019 - 2:00PM
Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart
Symbol: DPD2) (“Imagin” or the “Company”), an emerging leader in
the development and commercialization of advanced medical imaging
technologies, announced today that its financial results for the
second fiscal quarter ended March 31, 2019, will be released after
market close on Tuesday, June 11, 2019.
Imagin management will host a conference call at
5:00 p.m. ET to review the financial results and discuss business
developments in the period.
Second Fiscal Quarter 2019 Results
Conference Call Details: |
|
|
Date: |
June 11, 2019 |
|
|
Time: |
5:00 p.m. ET |
|
|
Live Call: |
888-390-3983 (Canada and the United States) |
|
862-298-0702 (International) |
|
|
Replay: |
919-882-2331 |
Replay ID: |
49416 |
The call will also be broadcast live and
archived on the Company's website at www.imaginmedical.com
under "Events & Presentations."
About Imagin Medical
Imagin Medical is a surgical imaging company
focused on establishing a new standard of care in visualizing
cancer during minimally invasive surgeries. The Company believes
its first product, the i/Blue™ Imaging System, will dramatically
improve surgeons’ ability to visualize cancerous cells by producing
higher-quality images more quickly compared with current methods.
Based on advanced optics and light sensors, the i/Blue Imaging
System employs patented ultrasensitive imaging technology and
offers easy-to-use viewing options for more accurate resection. The
Company’s initial focus is bladder cancer. Learn more at
www.imaginmedical.com.
Forward-Looking Statements
Information set forth in the corporate
presentation referenced in this press release contains
forward-looking statements. These statements reflect management’s
current estimates, beliefs, intentions and expectations; they are
not guarantees of future performance. The Company cautions that all
forward-looking statements are inherently uncertain, and that
actual performance may be affected by a number of material factors,
many of which are beyond the Company’s control. Accordingly, actual
and future events, conditions and results may differ materially
from the estimates, beliefs, intentions and expectations expressed
or implied in the forward-looking information. Specifically, there
is no assurance the Company’s imaging system will work in the
manner expected. Except as required under applicable
securities legislation, the Company undertakes no obligation to
publicly update or revise forward-looking information. The CSE has
neither approved nor disapproved the information contained herein
and does not accept responsibility for the adequacy or accuracy of
this news release.
Contact:
Stephen Kilmer, Investor Relations Telephone:
647-872-4849Email: stephen@kilmerlucas.com
Jim Hutchens, President & CEOTelephone:
833-246-2446
NR-2019-IME #33
Grafico Azioni Imi Medical Innovations (AMEX:IME)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Imi Medical Innovations (AMEX:IME)
Storico
Da Dic 2023 a Dic 2024
Notizie in Tempo Reale relative a Imi International Medical Innovations (Borsa Americana (AMEX)): 0 articoli recenti
Più Articoli Notizie